Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 52151-52200 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05700565
Treatment of Immune-related Adverse Events Refractory to Standard Therapy and Associated Changes in Immunophenotype
N/ARecruiting
50 participants
Started: Jan 1, 2022 · Completed: Jan 1, 2027
1 condition1 sponsor1 location
NCT05408897
Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD
N/ARecruiting
45 participants
Started: Jan 1, 2022 · Completed: Apr 30, 2028
2 conditions1 sponsor1 location
NCT04699799
Characterization of Human Olfactory Amygdala Subregions
NARecruiting
100 participants
Started: Jan 1, 2022 · Completed: Apr 1, 2026
1 condition1 sponsor1 location
NCT05607368
Mast Cells Are Involved in the Mechanism of NPSLE Epilepsy
N/ARecruiting
45 participants
Started: Jan 1, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05214612
Predictors and Prognostic Factors of Myasthenia Gravis Outcome
N/ARecruiting
30 participants
Started: Jan 1, 2022 · Completed: Mar 31, 2025
12 conditions1 sponsor1 location
NCT06345521
Etablishment of Follow-up System and End-Stage Heart Registration Platform for Pediatric Heart Failure
N/ARecruiting
100 participants
Started: Jan 1, 2022 · Completed: Dec 31, 2024
3 conditions3 sponsors1 location
NCT05494021
China Lung Cancer Screening (CLUS) Study Version 3.0
NARecruiting
100,000 participants
Started: Jan 1, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05527704
the Inhaled β2-adrenergic Receptor Agonist for Transient Tachypnoea of the Newborn (the REFSAL Trial)
PHASE3Recruiting
608 participants
Started: Dec 31, 2021 · Completed: Sep 30, 2026
3 conditions9 sponsors1 location
NCT05541367
Estrogen Receptor (ER) PET/CT Imaging in Breast Cancer
N/ARecruiting
80 participants
Started: Dec 31, 2021 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT06192290
Home-based Transitional Telerehabilitation in Cardiac Recovery
NARecruiting
118 participants
Started: Dec 31, 2021 · Completed: Feb 1, 2024
2 conditions1 sponsor1 location
NCT05277272
INTO-HLH: A Disease Registry for Patients With Hemophagocytic Lymphohistiocytosis (HLH)
N/ARecruiting
200 participants
Started: Dec 31, 2021 · Completed: Jan 31, 2026
1 condition3 sponsors1 location
NCT05595226
Effect of RT3D-TEE-guided Mitral Valve Repair on Outcomes in Patients With Degenerative Mitral Valve Disease
NARecruiting
338 participants
Started: Dec 31, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05178056
Spinal Cord Stimulation and Respiration After Injury
NARecruiting
30 participants
Started: Dec 31, 2021 · Completed: Dec 31, 2030
4 conditions2 sponsors1 location
NCT04885985
ACOART BTK RENEW:A Post Market Clinical Study
NARecruiting
107 participants
Started: Dec 31, 2021 · Completed: Apr 1, 2027
1 condition1 sponsor1 location
NCT05179551
Achillestendinopathy Treated With Proximal Medial Gastrocnemius Recession
NARecruiting
60 participants
Started: Dec 31, 2021 · Completed: Dec 31, 2025
2 conditions2 sponsors2 locations
NCT05192122
Free from Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MRD
PHASE1Recruiting
50 participants
Started: Dec 31, 2021 · Completed: Jan 31, 2029
1 condition1 sponsor1 location
NCT05488379
Child Healthcare at MATER - Pediatric Study
NARecruiting
108 participants
Started: Dec 31, 2021 · Completed: Oct 31, 2025
1 condition3 sponsors1 location
NCT05176964
Chemotherapy and Tislelizumab With Split-course HFRT for Locally Advanced Rectal Cancer
N/ARecruiting
50 participants
Started: Dec 31, 2021 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT04890821
Early Feasibility Study of the Cardiac Implants Percutaneous Ring Annuloplasty System
NARecruiting
15 participants
Started: Dec 31, 2021 · Completed: Sep 30, 2027
1 condition1 sponsor2 locations
NCT05638425
Radiotherapy Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of NSCLC Patients With Symptomatic Brain Metastases
N/ARecruiting
20 participants
Started: Dec 31, 2021 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT05189093
Recombinant Humanized Anti-CD47/PD-1 Bifunctional Antibody HX009 in Patients With Relapsed/Refractory Lymphoma
PHASE1/PHASE2Recruiting
99 participants
Started: Dec 31, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05266534
The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic Tourniquets
NARecruiting
162 participants
Started: Dec 30, 2021 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT05510505
GVHD Prophylaxis by Addition of CD20 Monoclonal Antibody to the Conditioning Regimen in SAA With Treatment of Allo-HSCT
PHASE2Recruiting
100 participants
Started: Dec 30, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04181138
Primary Sclerosing Cholangitis in Children
N/ARecruiting
1,000 participants
Started: Dec 30, 2021 · Completed: May 31, 2029
3 conditions2 sponsors12 locations
NCT05326204
1 Versus 2 Hours Post Meal Glucose Monitoring in Gestational Diabetes on Treatment
N/ARecruiting
2,954 participants
Started: Dec 30, 2021 · Completed: Dec 29, 2025
2 conditions1 sponsor1 location
NCT04894734
Spinal Cord Stimulation (SCS) for Spinal Cord Injury (SCI)
NARecruiting
30 participants
Started: Dec 30, 2021 · Completed: Oct 31, 2027
6 conditions1 sponsor1 location
NCT06456697
Pipeline Embolization Device for the Treatment of Intracranial Aneurysms on the Long Term Safety and Efficacy
N/ARecruiting
482 participants
Started: Dec 30, 2021 · Completed: Dec 30, 2024
1 condition10 sponsors1 location
NCT04799548
A Phase II Study of TACE Plus PD-1 Antibody in the Locally Advanced Stomach Adenocarcinoma
PHASE2Recruiting
71 participants
Started: Dec 30, 2021 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT05225948
Effects of Remote Ischemic Conditioning on Dynamic Cerebral Autoregulation, Blood Pressure and Heart Rate Variability in Patients With Cerebral Small Vessel Disease
NARecruiting
100 participants
Started: Dec 30, 2021 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05197530
Imaging of Lymphatic Vessels in People with Rheumatoid Arthritis (RA)
PHASE1Recruiting
40 participants
Started: Dec 30, 2021 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT06779747
Evaluation of Different Diagnostic Therapeutic Strategies in Patients with Thyroid Pathology
N/ARecruiting
5,850 participants
Started: Dec 30, 2021 · Completed: Dec 30, 2041
4 conditions1 sponsor1 location
NCT05053646
This is a Study to Verify if Marrow Venting Procedure Can Improve Meniscal Suture Healing
NARecruiting
80 participants
Started: Dec 29, 2021 · Completed: Oct 1, 2030
1 condition1 sponsor2 locations
NCT06252948
Gut Microbiome Studies in Patients With POEMS Syndrome and Other Plasma Cell Disorders
N/ARecruiting
240 participants
Started: Dec 29, 2021 · Completed: Dec 29, 2028
1 condition1 sponsor1 location
NCT05170503
Neoadjuvant Immunochemotherapy in Locally Advanced Esophagogastric Junction Adenocarcinoma
PHASE2Recruiting
37 participants
Started: Dec 29, 2021 · Completed: Jan 1, 2029
1 condition1 sponsor1 location
NCT04947319
Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study)
PHASE2Recruiting
112 participants
Started: Dec 29, 2021 · Completed: Mar 31, 2027
2 conditions1 sponsor45 locations
NCT05630963
Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression
N/ARecruiting
228 participants
Started: Dec 29, 2021 · Completed: Feb 28, 2027
1 condition2 sponsors1 location
NCT05120505
Metformin in Children With Fragile X Syndrome
PHASE4Recruiting
20 participants
Started: Dec 29, 2021 · Completed: Dec 30, 2025
2 conditions1 sponsor1 location
NCT05902247
Actium-225-Prostate Specific Membrane Antigen Imaging & Therapy
PHASE1Recruiting
30 participants
Started: Dec 29, 2021 · Completed: Dec 29, 2025
1 condition2 sponsors1 location
NCT05045066
Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients
EARLY_PHASE1Recruiting
200 participants
Started: Dec 29, 2021 · Completed: Aug 31, 2029
4 conditions1 sponsor2 locations
NCT05152732
Safety and Tolerability of VGB-R04 in Patients With Haemophilia B
EARLY_PHASE1Recruiting
3 participants
Started: Dec 28, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05017545
Carfilzomib and Belatacept for Desensitization
PHASE1/PHASE2Recruiting
15 participants
Started: Dec 28, 2021 · Completed: Feb 28, 2028
1 condition5 sponsors1 location
NCT05126589
Respiratory Virus Metagenomics After COVID-19
N/ARecruiting
500 participants
Started: Dec 28, 2021 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT04731610
Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete Resection of Stage II/III Thymoma (RADIO-RYTHMIC-01)
NARecruiting
314 participants
Started: Dec 28, 2021 · Completed: Dec 28, 2029
1 condition1 sponsor20 locations
NCT05147467
Study of APG-2575 in Patients With Relapsed/Refractory CLL/SLL
PHASE2Recruiting
75 participants
Started: Dec 28, 2021 · Completed: Dec 31, 2024
2 conditions1 sponsor11 locations
NCT04925479
Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia
PHASE1/PHASE2Recruiting
44 participants
Started: Dec 27, 2021 · Completed: Nov 1, 2031
1 condition1 sponsor40 locations
NCT04676802
Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone
PHASE2Recruiting
121 participants
Started: Dec 27, 2021 · Completed: Aug 31, 2027
2 conditions1 sponsor2 locations
NCT05188885
A Real World, Multi-centric, Observational Registry Study of Chronic Kidney Diseases
N/ARecruiting
90,000 participants
Started: Dec 27, 2021 · Completed: Dec 27, 2028
1 condition1 sponsor8 locations
NCT06363032
Elastography in Predicting Renal Outcome
N/ARecruiting
500 participants
Started: Dec 27, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05418764
Effect of Validated Skills Simulation With the Miya Model
NARecruiting
70 participants
Started: Dec 27, 2021 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05181033
Lenvatinib+Letrozole Versus Fulvestrant in Metastatic ER+/HER2- Breast Cancer, Post Progression on Al + CDK4/6 Inhibitor
PHASE2Recruiting
120 participants
Started: Dec 27, 2021 · Completed: Aug 31, 2027
1 condition2 sponsors1 location